1 READ MORE: GLP-1 Agonists Associated with Doubled Risk of Neovascular AMD, Study Finds NAION moves the discussion beyond the retina A 2024 matched cohort study reporting increased NAION incidence among semaglutide-prescribed patients drew wide attention across ophthalmology, prompting debate over whether the association reflects a true optic nerve safety signal or the underlying vascular risk profiles of diabetic and obese populations
This condition typically develops gradually due to prolonged high blood sugar
Together, they aim to introduce new products tailored to individual patient needs, showing the industry's focus on targeted treatment approaches
Large-scale clinical trials tracking once-weekly therapies show that symptoms are typically mild-to-moderate, temporary, and highly dose-dependent
Slow and steady titration produces better outcomes than aggressive dose escalation
If you notice any new changes in your vision, contact your doctor of optometry right away
